Literature DB >> 3487983

Prevalence of smoking among psychiatric outpatients.

J R Hughes, D K Hatsukami, J E Mitchell, L A Dahlgren.   

Abstract

The prevalence of smoking among psychiatric outpatients (N = 277) was significantly higher than among either local or national population-based samples (N = 1,440 and 17,000) (52% versus 30% and 33%). The higher prevalence was not associated with the age, sex, marital status, socioeconomic status, alcohol use, coffee use, or institutionalization of the psychiatric patients. Smoking was especially prevalent among patients with schizophrenia (88%) or mania (70%) and among the more severely ill patients. Hypotheses about why psychiatric patients are more likely to smoke and why they do not have a high rate of smoking-induced illnesses are presented.

Entities:  

Mesh:

Year:  1986        PMID: 3487983     DOI: 10.1176/ajp.143.8.993

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  207 in total

Review 1.  Antipsychotic-induced venous thromboembolism: a review of the evidence.

Authors:  Staffan Hägg; Olav Spigset
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

2.  Predictors of Tobacco Use Among New York State Addiction Treatment Patients.

Authors:  Joseph Guydish; Jiang Yu; Thao Le; Anna Pagano; Kevin Delucchi
Journal:  Am J Public Health       Date:  2015-01       Impact factor: 9.308

3.  Let the patients smoke: a defence of a patient privilege.

Authors:  M Lavin
Journal:  J Med Ethics       Date:  1990-09       Impact factor: 2.903

4.  Outcome in smoking cessation.

Authors:  S A Cooper; A Mlynik-Szmid
Journal:  Br J Gen Pract       Date:  1992-10       Impact factor: 5.386

5.  Nicotine blocks latent inhibition in rats: evidence for a critical role of increased functional activity of dopamine in the mesolimbic system at conditioning rather than pre-exposure.

Authors:  M H Joseph; S L Peters; J A Gray
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  Nicotine restores Wt-like levels of reelin and GAD67 gene expression in brain of heterozygous reeler mice.

Authors:  Emilia Romano; Andrea Fuso; Giovanni Laviola
Journal:  Neurotox Res       Date:  2013-02-06       Impact factor: 3.911

Review 7.  Treating schizophrenia symptoms with an alpha7 nicotinic agonist, from mice to men.

Authors:  Ann Olincy; Karen E Stevens
Journal:  Biochem Pharmacol       Date:  2007-07-17       Impact factor: 5.858

Review 8.  Nicotinic interactions with antipsychotic drugs, models of schizophrenia and impacts on cognitive function.

Authors:  Edward D Levin; Amir H Rezvani
Journal:  Biochem Pharmacol       Date:  2007-07-20       Impact factor: 5.858

9.  Low monoamine oxidase B in peripheral organs in smokers.

Authors:  Joanna S Fowler; Jean Logan; Gene-Jack Wang; Nora D Volkow; Frank Telang; Wei Zhu; Dinko Franceschi; Naomi Pappas; Richard Ferrieri; Colleen Shea; Victor Garza; Youwen Xu; David Schlyer; S John Gatley; Yu-Shin Ding; David Alexoff; Donald Warner; Noelwah Netusil; Pauline Carter; Millard Jayne; Payton King; Paul Vaska
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-12       Impact factor: 11.205

10.  Depression and smoking in pregnancy in Scotland.

Authors:  C W Pritchard
Journal:  J Epidemiol Community Health       Date:  1994-08       Impact factor: 3.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.